The Glass Bottles and Vials for Vaccines and Pharmaceutical Market is Expected to grow at a 7.7% CAGR during the forecast period of 2024-2031.
Key Industry Insights & Findings from the Report:
A vial is a small glass or plastic container that stores medication in powders, liquids, and capsules (also referred to as a flacon or phial). The demand for glass bottles and vials has increased due to end users using glass vials more frequently than conventional vials. Since they make recycling simple, they are also eco-friendly. Glass bottles and vials allow producers to lower production costs while providing consumers with items of higher quality. As the demand for pharmaceutical packaging surges, it opens up the potential for marketers to sell the vaccine and pharmaceutical glass bottles and vials. As chances for marketers are created by a rise in demand for pharmaceutical packaging, the glass bottles and vials for vaccines and the pharmaceutical industry are rising. Leading industry players are spending money to improve their market position. A vial maker, SCHOTT AG, recently invested US $333 million in pharmaceutical packaging to grow its glass tubing business. Global market companies are attempting to increase their product offerings and global presence in this industry.
Since the COVID-19 pandemic, the demand for glass bottles and vials used for pharmaceutical and vaccination products has grown exponentially. Following the COVID-19 vaccines' approval, vaccination campaigns have been launched in numerous nations. Due to the enormous demand for glass bottles and vials for vaccine packaging from vaccine makers, the market is expanding. In addition, the market for glass bottles and vials for pharmaceuticals and vaccines will be significantly constrained by the rising cost of the overall packaging.
The Glass Bottles and Vials for Vaccines and Pharmaceutical market is segmented based on application and end-user. Based on application, the market is segmented into vaccines and general medicine. Based on end-user, the glass bottles and vials for vaccines and pharmaceutical is segmented into hospital, drug manufacturers, diagnostic centers and others.
Based on application, the market is segmented into vaccines and general medicine. The vaccine segment dominated the market. Vaccine vials are used in pharmaceutical packaging. The vaccination vial is a compact cylindrical container that can be utilized in industries such as pharmaceutical, medical, environmental, and lab testing. There are several varieties of vaccine vials available, including single dosage and multi-dose vials. Increased investment in glass vaccine vials, particularly in the pharmaceutical industry, increased vaccine production, and rising government initiatives in the biochemical industry are key drivers projected to fuel the growth of the vaccine vials market.
Based on end-user, the glass bottles and vials for vaccines and pharmaceutical is segmented into hospital, drug manufacturers, diagnostic centers and others. The hospital category dominated the market. The need for glass bottles and vials has increased due to their expanding use by hospitals. In hospitals, glass bottles and vials are frequently used to store medications and samples. Over the past ten years, glass bottles and vials have grown in popularity in hospitals because they are non-reactive, have a long shelf life, and are contamination-free.
The North America Glass Bottles and Vials for Vaccines and Pharmaceutical market is expected to register the highest market share in revenue in the near future. Pharmaceutical spending in developing nations is expected to rise in the coming years. With innovative products driving the rise, the United States is projected to be a prominent driver and the region's most important market for expanding the pharmaceutical sector. This expansion is predicted to be aided by an increase in generics in the region, which are expected to maintain high volume and sales demand. In addition, Asia Pacific is projected to grow rapidly in the global Glass Bottles and Vials for Vaccines and Pharmaceutical market. Chronic disease incidence increased healthcare expertise, and rising income levels will help Asia Pacific emerging markets expand. Governments in the Asia Pacific region are expanding their private and public healthcare coverage due to increased knowledge. Government actions in emerging countries to encourage low-cost generic drugs and lower healthcare costs are projected to raise the volume of pharmaceutical products, encouraging the region's market expansion even further.
| Report Attribute | Specifications |
| Growth rate CAGR | CAGR of 7.7% from 2024 to 2031 |
| Quantitative units | Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments covered | Product Type, Crop Type, Application, End-User |
| Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | SCHOTT AG, Thermo Fisher Scientific, ZHENGCHUAN ICP, Cang Zhou Four-star Glass Co., Ltd, Stevanato Group PIVA, Gerresheimer AG, SGD Pharma, Qorpak, Corning Incorporated and SM PACK. |
| Customization scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and available payment methods | Explore pricing alternatives that are customized to your particular study requirements. |
By Product Type-
By Application-
By End-User
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.